CClinicalTrials.gg
RecruitingNCT06765538VIDFACEUpdated Feb 3, 2025

Video Versus Face-to-face Preoperative Anaesthetic Assessment

An interventional study of Video consultation in Anesthesia and Telemedicine, sponsored by Rigshospitalet, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-03.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Apr 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,260
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized clinical trial rewieving difference between anaesthetic preassessment in physical consultations vs. video consultations.

Read the detailed description

Preoperative anaesthetic assessment aims to reduce morbidity and mortality and are currently accepted as the gold standard of care for elective surgery. Technical advances in society have led to explora-tions within the telemedicine area which continues providing safe and effective services. The video versus face-to-face preoperative anaesthetic assessment (VIDFACE) trial aims to compare videobased preoperative anaesthetic assessment to standard face-to-face consultations with focus on patient safety and satisfaction including possible beneficial eco and economical effects compared to standard face-to-face consultations.

This is a randomised, single-centre, two-arm, assessor, and data analyst blinded clinical trial. We will enrol 2260 participants undergoing elective Ear-Nose-Throat or Tooth-Mouth-Jaw surgery. Participants will be randomised 1:1 stratified by malignant versus benign surgery to either video based preoperative anaesthetic assessment or face-to-face consultation. Data will be analysed by two blinded statisticians, and we will write abstracts covering all possible combinations of conclusions, before breaking the blind.

Results:

The primary outcome is the incidence of six predefined serious adverse events (SAE). Secondary outcomes are the proportion of participant with a change in anaesthesia plan as well as delays or cancellations on the day of surgery and patient satisfaction.

The VIDFACE trial will contribute valuable knowledge on the efficacy and safety on using video consultations in the an-aesthetic preoperative assessment.

02

Conditions studied

  • Anesthesia
  • Telemedicine

Keywords

  • anaesthetic preassessment
  • telemedicine
03

In context

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ENT and TMJ patients
  • Adults > 18 years
  • Informed consent obtained after a consideration period of minimum 24 hours

Exclusion criteria

Exclusion Criteria:

  • If a patient is assessed unsuitable for the video technology in example, patients with severe mental challenges (dementia, retardation, etc.), they will not be included in the trial. If excluded, the patient receives standard care, face-to-face preoperative anaesthetic assessment.
  • Local protocol screen patients
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
2,260 participants (estimated)

Study arms

  • Experimental
    Video consultation

    Patients receiving video consultations

    Other: Video consultation

  • No intervention
    Physical consultation

    Patients receiving physical consultations (standard care)

Interventions

  • OtherVideo consultation

    Preanaesthetic videoconsultation

06

What researchers measure

Primary outcomes

  1. SAE

    All-cause mortality, all-cause admission to intensive care unit, bleeding requiring transfusion, infection requiring antibiotics, hospital readmission or prolonged hospitalization.

    Time frame: 30 day follow up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06765538
Lead sponsor
Rigshospitalet, Denmark
Responsible party
Katrine Bredahl Buggeskov (Principal Investigator, Rigshospitalet, Denmark) — Principal investigator
First posted
Jan 9, 2025
Start date
Nov 4, 2024
Primary completion
Apr 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Feb 3, 2025

Study contacts

Katrine Bredahl Buggeskov, Doctor
Contact
katrine.bredahl.buggeskov@regionh.dk
+45 51921299

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion